SCHEMBL26124848

SCHEMBL26124848

O=c1[nH]oc2ccc(Br)cc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 3/20 0.53
▸ PIM1 P11309 4/20 0.46
▸ CHEK1 O14757 2/20 0.46
▸ FLT3 P36888 2/20 0.46
▸ AURKA O14965 1/20 0.46
▸ DAPK3 O43293 1/20 0.46
▸ JAK2 O60674 1/20 0.46
▸ PRKD3 O94806 1/20 0.46
▸ MAP4K4 O95819 1/20 0.46
▸ PAK4 O96013 1/20 0.46
▸ ABL1 P00519 1/20 0.46
▸ NTRK1 P04629 1/20 0.46
▸ CSF1R P07333 1/20 0.46
▸ RET P07949 1/20 0.46
▸ MET P08581 1/20 0.46
▸ PDGFRB P09619 1/20 0.46
▸ FGFR1 P11362 1/20 0.46
▸ PDGFRA P16234 1/20 0.46
▸ PRKACA P17612 1/20 0.46
▸ FLT1 P17948 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11514807 0.89 PTPN1 (0.46) DAOPIM1CHEK1FLT3AURKA
SCHEMBL11583004 0.87 PTPN1 (0.45) DAOPIM1CHEK1FLT3AURKA
SCHEMBL11583007 0.87 PTPN1 (0.45) DAOPIM1CHEK1FLT3AURKA
SCHEMBL3526289 0.84 DAO (0.61) DAOPIM1CHEK1FLT3AURKA
SCHEMBL30716975 0.76 DAO (0.53) DAOAKR1C3AKR1C2PTPN1GABRP
SCHEMBL481873 0.76 DAO (0.72) DAOPIM1CLK2GSK3AGSK3B
SCHEMBL14644667 0.76 DAO (0.53) DAOAKR1C3AKR1C2
SCHEMBL482202 0.76 DAO (0.53) DAOAKR1C3AKR1C2PTPN1GABRP
SCHEMBL31538134 0.76 DAO (0.53) DAOAKR1C3AKR1C2
SCHEMBL1431071 0.73 PIM1 (0.50) PIM1CHEK1FLT3AURKADAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 — — WO disclosed
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 — — WO disclosed
CN-103382187-B 3-chloro-7(5)-bromo-benzo-isoxazole compounding method SYNTHESIS MED SHANGHAI CO LTD 2015-06-03 — — CN disclosed
CN-103382187-A 3-chloro-7(5)-bromo-benzo-isoxazole compounding method SYNTHESIS MED SHANGHAI CO LTD 2013-11-06 — — CN disclosed
Send feedback